Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 13 | $14,743,631 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Feb 2025 21:20 | AXSM | Axsome Therapeutics Inc | PIZZIE NICK | Chief Financial Officer | 13 Feb 2025 | Sale | 12,000 | 129.86 | 1,558,320 | D |
| 14 Feb 2025 21:20 | AXSM | Axsome Therapeutics Inc | PIZZIE NICK | Chief Financial Officer | 14 Feb 2025 | Sale | 3,000 | 131.07 | 393,210 | D |
| 11 Sep 2024 19:00 | AXSM | Axsome Therapeutics Inc | SAAD MARK E | Director | 11 Sep 2024 | Sale | 11,016 | 91.31 | 1,005,871 | D |
| 09 Aug 2024 19:27 | AXSM | Axsome Therapeutics Inc | JACOBSON MARK L. | Chief Operating Officer | 09 Aug 2024 | Sale | 47,739 | 84.26 | 4,022,488 | D |
| 29 May 2024 20:12 | AXSM | Axsome Therapeutics Inc | JACOBSON MARK L. | Chief Operating Officer | 29 May 2024 | Sale | 7,910 | 74.3127 | 587,813 | D |
| 29 May 2024 20:11 | AXSM | Axsome Therapeutics Inc | COLEMAN MARK | Director | 29 May 2024 | Sale | 5,248 | 75.1396 | 394,333 | D |
| 29 May 2024 20:11 | AXSM | Axsome Therapeutics Inc | COLEMAN MARK | Director | 28 May 2024 | Sale | 5,249 | 75.2095 | 394,775 | D |
| 01 Apr 2024 18:46 | AXSM | Axsome Therapeutics Inc | JACOBSON MARK L. | Chief Operating Officer | 01 Apr 2024 | Sale | 24,662 | 77.242 | 1,904,942 | D |
| 15 Mar 2024 20:05 | AXSM | Axsome Therapeutics Inc | JEFFS ROGER | Director | 15 Mar 2024 | Sale | 2,347 | 71.6072 | 168,062 | D |
| 15 Mar 2024 20:05 | AXSM | Axsome Therapeutics Inc | JEFFS ROGER | Director | 14 Mar 2024 | Sale | 16,976 | 69.702 | 1,183,261 | D |
| 15 Mar 2024 20:05 | AXSM | Axsome Therapeutics Inc | JEFFS ROGER | Director | 14 Mar 2024 | Sale | 13,000 | 69.702 | 906,126 | D |
| 15 Sep 2023 18:30 | AXSM | Axsome Therapeutics Inc | COLEMAN MARK | Director | 15 Sep 2023 | Sale | 18,572 | 75.1771 | 1,396,189 | I |
| 15 Sep 2023 18:30 | AXSM | Axsome Therapeutics Inc | COLEMAN MARK | Director | 15 Sep 2023 | Sale | 11,016 | 75.1853 | 828,241 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)